Photo: Jhpiego

Madagascar

Since 2003, we have worked in these technical areas:

Family Planning and Reproductive Health

Malaria Prevention and Treatment

Maternal, Newborn and Child Health

Gender

Infection Prevention and Control

Digital Health

Our impact

  • More than 46,000 pregnant women in 15 regions received the recommended three doses of intermittent preventive treatment for malaria at health care facilities supported by the Maternal and Child Survival Program (MCSP), thereby being protected from potential malaria-related complications in pregnancy.
  • At 666 MCSP-supported health care facilities, the percentage of women screened for pre-eclampsia and eclampsia during antenatal care services rose from 47% at baseline to 94%, and the percentage of women who received a uterotonic immediately after birth to prevent postpartum hemorrhage increased from 89% to 100%.
  • MCSP supported access to postpartum family planning (PPFP) services by building the capacity of 736 health care providers, contributing to more than 14,000 women receiving PPFP counseling and leading to an increase of PPFP uptake from 8% to 24% at 230 facilities in a single year.

Current programs


  • Maternal and Child Survival Program

    The U.S. Agency for International Development’s Bureau for Global Health’s flagship Maternal and Child Survival Program (MCSP) focuses on 25 high-priority countries with the ultimate goal of preventing child and maternal deaths. MCSP is introducing and supporting high-impact, sustainable reproductive, maternal, newborn and child health (RMNCH) interventions in partnership with ministries of health and other partners. In addition to contributing to high-level technical and policy dialogue at the global level, MCSP provides tailored technical assistance to help countries meet specific priorities and contextual needs of local, sustainable RMNCH programs. For information on what MCSP is doing in this country, visit here: http://www.mcsprogram.org/where-we-work/madagascar/.

  • Transforming Intermittent Preventive Treatment for Optimal Pregnancy

    Under this Unitaid-funded, five-year grant, Jhpiego is partnering with ISGlobal to reduce maternal and neonatal mortality in the Democratic Republic of Congo, Nigeria, Madagascar and Mozambique by: 1) introducing and setting the stage for scale-up of community intermittent preventive treatment of malaria in pregnancy (IPTp); 2) introducing and increasing demand for quality-assured sulfadoxine-pyrimethamine (SP) for IPTp; and 3) generating evidence for World Health Organization policy change. To achieve desired results, Jhpiego is also collaborating with Medicines for Malaria Venture (to bring quality-assured SP to market) and the World Health Organization (to ensure SP resistance monitoring and foster collaboration between national reproductive health programs and national malaria control programs). For more information, visit here: www.tiptopmalaria.org.

Current programs

Maternal and Child Survival Program

The U.S. Agency for International Development’s Bureau for Global Health’s flagship Maternal and Child Survival Program (MCSP) focuses on 25 high-priority countries with the ultimate goal of preventing child and maternal deaths. MCSP is introducing and supporting high-impact, sustainable reproductive, maternal, newborn and child health (RMNCH) interventions in partnership with ministries of health and other partners. In addition to contributing to high-level technical and policy dialogue at the global level, MCSP provides tailored technical assistance to help countries meet specific priorities and contextual needs of local, sustainable RMNCH programs. For information on what MCSP is doing in this country, visit here: http://www.mcsprogram.org/where-we-work/madagascar/.

Transforming Intermittent Preventive Treatment for Optimal Pregnancy

Under this Unitaid-funded, five-year grant, Jhpiego is partnering with ISGlobal to reduce maternal and neonatal mortality in the Democratic Republic of Congo, Nigeria, Madagascar and Mozambique by: 1) introducing and setting the stage for scale-up of community intermittent preventive treatment of malaria in pregnancy (IPTp); 2) introducing and increasing demand for quality-assured sulfadoxine-pyrimethamine (SP) for IPTp; and 3) generating evidence for World Health Organization policy change. To achieve desired results, Jhpiego is also collaborating with Medicines for Malaria Venture (to bring quality-assured SP to market) and the World Health Organization (to ensure SP resistance monitoring and foster collaboration between national reproductive health programs and national malaria control programs). For more information, visit here: www.tiptopmalaria.org.

Current and recent donors


Unitaid
USAID

Madagascar-related technical and programmatic resources

Our resources

Country contact

Eliane Razafimandimby, MCSP Chief of Party/Jhpiego Country Director
Tel. 261 2022 31 220
Immeuble Santa Lot II, 3rd Floor Antanimena
Antananarivo, Madagascar